Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
FGEN | F | FibroGen, Inc | 4.43 | |
MRSN | F | Mersana Therapeutics, Inc. | -0.54 | |
IMUX | F | Immunic, Inc. | -5.68 | |
APRE | F | Aprea Therapeutics, Inc. | 3.19 | |
LXRX | F | Lexicon Pharmaceuticals, Inc. | 0.60 | |
ATRA | F | Atara Biotherapeutics, Inc. | 7.39 | |
VTGN | F | VistaGen Therapeutics, Inc. | 2.72 | |
MCRB | F | Seres Therapeutics, Inc. | 15.70 | |
EQ | F | Equillium, Inc. | 2.70 | |
ONCT | F | Oncternal Therapeutics, Inc. | 0.14 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
XBI | C | SPDR S&P Biotech ETF | 3.76 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 3.05 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 2.91 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 2.64 | |
LABU | C | Direxion Daily S&P Biotech Bull 3X Shares | 2.44 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles